Trump's big promises on drug costs followed by modest steps
WASHINGTON (AP) — President Donald Trump makes big promises to reduce prescription drug costs, but his administration is gravitating to relatively modest steps such as letting Medicare patients share in manufacturer rebates.
Those ideas would represent tangible change and they have a realistic chance of being enacted. But it's not like calling for Medicare to negotiate drug prices.
Skeptics say the overall approach is underwhelming, and Trump risks being seen as an ally of the powerful pharmaceutical industry, not its disrupter.
The White House Council of Economic Advisers has released a... read more
- 16:00 Texas Republican Rep. Will Hurd says Trump is being manipulated by...
- 13:56 The Latest: AP source: Trump on tape about Playmate payment
- 13:01 NY Times: Trump was recorded talking of paying Playboy model
- 12:33 As trial ends, U.S. judge questions constitutionality of Texas...
- 12:04 Trump heightens tariff threat in trade war with China
- 11:23 Japan's Abe: US auto tariffs will cost US jobs, harm economy
- 06:59 Statewide data shows Texas anti-vaccine movement is growing
- 05:13 Trump slams rate increases by independent Federal Reserve
- 01:42 Translators stay in shadows, but Dems want Trump's to emerge
- 00:45 Trump-Putin II: Planning fall event in aftermath of Helsinki